Ameliora Wealth Management’s AbbVie ABBV Stock Holding History

Ameliora Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19.6K	Hold	78	–	–	0.01%	189
2026 Q1	$17K	Buy	+78	New	+$17.3K	0.01%	198
2025 Q3	–	Sell	-477	Closed	-$88.5K	–	222
2025 Q2	$88.5K	Hold	477	–	–	0.03%	138
2025 Q1	$99.9K	Sell	477 -523	-52%	-$102K	0.04%	135
2024 Q4	$178K	Hold	1,000	–	–	0.07%	104
2024 Q3	$197K	Sell	1,000 -700	-41%	-$131K	0.08%	83
2024 Q2	$292K	Hold	1,700	–	–	0.13%	71
2024 Q1	$310K	Buy	1,700 +1,000	+143%	+$172K	0.14%	73
2023 Q4	$108K	Sell	700 -92	-12%	-$13.4K	0.05%	92
2023 Q3	$118K	Buy	792 +92	+13%	+$13.5K	0.07%	94
2023 Q2	$94.3K	Hold	700	–	–	0.06%	102
2023 Q1	$112K	Hold	700	–	–	0.07%	103
2022 Q4	$113K	Hold	700	–	–	0.06%	95
2022 Q3	$97K	Buy	+700	New	+$100K	0.05%	101

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Ameliora Wealth Management's ABBV Position: Q2 2026 in Review

Ameliora Wealth Management held its AbbVie (ABBV) position steady in Q2 2026 at 78 shares worth $19.6K. The position accounts for 0.01% of the portfolio, ranked #189.

Ameliora Wealth Management first reported a position in ABBV in Q3 2022 and has held it in 14 quarters since. The position peaked at $310K in Q1 2024. 4,188 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Ameliora Wealth Management held 78 shares of AbbVie worth $19.6K as of Q2 2026.
Ameliora Wealth Management left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.01% of Ameliora Wealth Management's portfolio in Q2 2026, its #189 holding.
Ameliora Wealth Management first reported a position in AbbVie in Q3 2022 and has held it in 14 quarters since.
Ameliora Wealth Management's AbbVie position peaked at $310K in Q1 2024.
4,188 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Ameliora Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.